United Therapeutics (UTHR) Shares Repurchased (2010 - 2026)

United Therapeutics has disclosed Shares Repurchased across 14 years of filings, most recently posting $1.5 billion for Q1 2026.

• Shares Repurchased for Q1 2026 came in at $1.5 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 billion (changed N/A YoY), and the FY2025 annual result was $1.0 billion, changed 0.0% from the prior year.
• Shares Repurchased came in at $1.5 billion for Q1 2026 at United Therapeutics, up from $1.0 billion in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $1.5 billion in Q1 2026 to a low of $1.0 billion in Q1 2024.
• The 3-year median for Shares Repurchased is $1.0 billion (2024), against an average of $1.2 billion.